News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
robot merck
PETRA: The potencial of medical robots
The robot facilitates thyroid diagnosis by interacting with humans and making an assessment based…
Partners - Merck
Dámaso Melero 2021
#InterviewBiospain2021 | The company born drinking a beer that ended up as the first to develop biosimilars in Spain
BioSpain
3P Biopharmaceuticals operates globally, with 19 active projects worldwide and has positioned…
AseBio - 3PBIOVIAN
bcn health newsletter en ingles
BCN HEALTH has participated in the "Global Thalassaemia Review 2021 Report" developed by the Thalassaemia International Federation
Healthcare
With the data obtained in the targeted literature, a cost-of-illness model has been developed to…
Partners - BCN Health
foto algenex
The EMA validates Algenex's CrisBio® technology platform, for the manufacture of vaccines
This European recommendation has validated the use of this technology to produce recombinant…
Partners - Algenex
imagen foto genesis biomed
A FECYT report concludes that the entire innovation incentive scheme needs to be redesigned
GENESIS Biomed has participated in the preparation of the THINK TANK report "Patenting and/or…
Partners - GENESIS Biomed
foto de medicina de precisión
Personalised medicine increases its activity by 40% in the last year and is becoming more decisive
Personalized medicine
Precision medicine and personalised medicine products or services have gone from representing 12%…
foto oyrzon
ORYZON receives approval to start EVOLUTION Phase IIb trial with vafidemstat in schizophrenia
Healthcare
Clinical Trial Application approved by Spanish Drug Agency  Primary objectives: to assess the…
Partners - Oryzon Genomics
FOTO ORYZON
ORYZON presents safety and efficacy data of vafidemstat from the Phase II ESCAPE trial in severe CoVID-19 patients at ECCMID-2021
Healthcare
Vafidemstat was safe and well tolerated  Confirmed anti-inflammatory activity of vafidemstat…
Partners - Oryzon Genomics
acorys equipment
Corify Care raises €2.35M to translate its cardiac mapping technology to the market
Healthcare · Personalized medicine · Financing
The investment round is led by Clave Capital, counting with investment from CDTI through its…
Partners - Corify Care